Back to Results
First PageMeta Content
Ipilimumab / Melanoma / Hematopoietic stem cell transplantation / Immunotherapy / Tremelimumab / Transplant rejection / PD-1 / CTLA-4 / Medicine / Transplantation medicine / Graft-versus-host disease


Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant
Add to Reading List

Open Document

File Size: 333,72 KB

Share Result on Facebook

Company

MEDLINE / Creative Commons / Google / /

Country

United States / /

/

Facility

Yale New Haven Hospital / Yale Smilow Cancer Hospital / Smilow Cancer Hospital / Yale Cancer Center / /

IndustryTerm

therapy for metastatic melanoma / immune systems / therapy of metastatic melanoma / treatment of melanoma / treatment of metastatic melanoma / therapies for melanoma / treatment for melanoma / treatment of cutaneous melanoma / online submission / /

MedicalCondition

also developed erythema / CNS disease / lymphoma / headache / rare / solid tumors / intracranial hemorrhage / blast crisis / graft-versus-host disease / several new metastases / angiosarcoma / solid tumors / pancytopenia / abdominal lymphadenopathy / skin rash / metastatic disease / deep ulcerated melanoma / second malignancy / melanoma / fatigue / progressive and extensive vitiligo / mild disease / subcarinal and paratracheal lymphadenopathy / vitiligo / MS / pruritus / active tissue inflammation / mild rash / hypotension / tumor / Graft vs host disease / Cancer / brain metastases / disease / L4 osteomyelitis / tumor BRAF / Curtis RE et al. Solid Cancers / host disease / tumour / axillary lymphadenopathy / seizure / Mild chills / mild aphasia / stable disease / cutaneous melanoma / Chronic Myeloid Leukemia / rash / metastatic melanoma occurring / metastatic melanoma / reported rash / /

MedicalTreatment

antibiotics / chemotherapy / bone marrow transplant / surgical treatment / ImmunoTherapy / gamma knife radiosurgery / total body irradiation / /

OperatingSystem

L3 / /

Organization

Yale New Haven Hospital / Yale / Yale Cancer Center / Yale University School of Medicine / Yale Smilow Cancer Hospital / Smilow Cancer Hospital / Division of Medical Oncology / Society for Immunotherapy of Cancer / /

Person

Michael DiGiovanna / Stuart Seropian Abstract Metastatic / Michael Cecchini / Mario Sznol / /

Position

Clinical Research Program Leader / Editor-In-Chief / Associate Professor / Professor of Medicine / /

Product

cyclosporine / FS / celebrex / taxol / /

Technology

Tomography / transplantation / MRI / chemotherapy / /

URL

http /

SocialTag